Merck, its place in the healthcare and biotechnology sector and full sector report
Includes full sector report with 17 healthcare and biotechnology companies, where Merck is analysed in relative perspective of Abbott Laboratories, Abbvie, Amgen, AstraZeneca plc, Bayer AG, Biogen, Bristol-Myers Squibb Co, Eli Lilly Co, Gilead Sciences, GlaxoSmithKline plc, Johnson & Johnson, Novartis, Novo Nordisk A/S, Pfizer, Roche Holding ltd. Gnns and Sanofi. Ready to implement with standard portfolio. This report makes it clear how to allocate funds within the healthcare and biotechnology sector and drives your outperformance. Targeted and expected outperformance is 10% per year on the upper half of companies and 5% per year on a diversified standard portfolio in the sector based on long term results and experience.
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The company's segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
Analist is and analysis by drs. E. (Erik) D. Molenaar RBA, RBA/CFA certified investment analist and EFFAS certified financial analist. Delivering to the point investment analysis. Apart from an absolute advice, a clear sector advice and overview, and/or a relative advice within the sector, is always included in the reports which makes the reports extremely usefull and helpfull for fund allocation within a sector.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.